Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients
Authors
Keywords
COVID 19, Lipid mediators, SARS CoV 2, Inflammation, Intensive care units, Blood plasma, Immune response, Eicosanoids
Journal
PLoS One
Volume 16, Issue 8, Pages e0256226
Publisher
Public Library of Science (PLoS)
Online
2021-08-27
DOI
10.1371/journal.pone.0256226
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study
- (2020) Christopher M Petrilli et al. BMJ-British Medical Journal
- Characterization of the Inflammatory Response to Severe COVID-19 Illness
- (2020) Oliver J McElvaney et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Characteristics and Outcomes of COVID-19 Patients During Initial Peak and Resurgence in the Houston Metropolitan Area
- (2020) Farhaan S. Vahidy et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 ARDS
- (2020) Sophie Hue et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
- (2020) Tamara S. Rodrigues et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators
- (2020) Benjamin Schwarz et al. JOURNAL OF IMMUNOLOGY
- Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis
- (2019) Romain A. Colas et al. FASEB JOURNAL
- Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
- (2018) Charles N. Serhan et al. JOURNAL OF CLINICAL INVESTIGATION
- Maresin1 stimulates alveolar fluid clearance through the alveolar epithelial sodium channel Na,K-ATPase via the ALX/PI3K/Nedd4-2 pathway
- (2017) Jun-Li Zhang et al. LABORATORY INVESTIGATION
- Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors
- (2017) Nan Chiang et al. MOLECULAR ASPECTS OF MEDICINE
- New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration
- (2017) Charles N. Serhan et al. MOLECULAR ASPECTS OF MEDICINE
- Acute Respiratory Distress Syndrome
- (2017) B. Taylor Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries
- (2016) Giacomo Bellani et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Critical role of phospholipase A2group IID in age-related susceptibility to severe acute respiratory syndrome–CoV infection
- (2015) Rahul Vijay et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation
- (2015) R E Abdulnour et al. Mucosal Immunology
- Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue
- (2014) Romain A. Colas et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- The Specialized Proresolving Mediator 17-HDHA Enhances the Antibody-Mediated Immune Response against Influenza Virus: A New Class of Adjuvant?
- (2014) Sesquile Ramon et al. JOURNAL OF IMMUNOLOGY
- The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza
- (2013) Masayuki Morita et al. CELL
- Lipidomic Profiling of Influenza Infection Identifies Mediators that Induce and Resolve Inflammation
- (2013) Vincent C. Tam et al. CELL
- Novel n-3 Immunoresolvents: Structures and Actions
- (2013) Jesmond Dalli et al. Scientific Reports
- Resolvin D1 and Aspirin-Triggered Resolvin D1 Promote Resolution of Allergic Airways Responses
- (2012) A. P. Rogerio et al. JOURNAL OF IMMUNOLOGY
- Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury
- (2012) O Eickmeier et al. Mucosal Immunology
- Genome-wide association analysis by lasso penalized logistic regression
- (2009) Tong Tong Wu et al. BIOINFORMATICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started